Cailin Sibley, MD

AnaptysBio
San Diego, CA, United States

Cailin Sibley, M.D., M.H.S. is Vice President and Head of Translational Medicine at AnapytsBio. She is a board-certified rheumatologist with a career spanning academic rheumatology to early clinical development and strategic leadership roles of increasing responsibility at Eli Lilly, Chinook Therapeutics, Janssen, and AnaptysBio. She is driven by a passion to bring the promise of precision medicine in immunologic diseases to reality and novel clinical approaches to the treatment of complex diseases.

Presentation(s):

• 0455: Rosnilimab, a Novel PD-1 Agonist Monoclonal Antibody, Inhibits Peripheral T Cell Proliferation and Cytokine Secretion and Reduces Circulating PD-1 High Expressing CD4 and CD8 T Cells: Results from a Phase 1 Healthy Volunteer Clinical Trial

  Sunday, November 12, 2023
  9:00 AM – 11:00 AM PT

  Disclosure information not submitted.